TY - JOUR AU - Makela, M. J. AU - Backer, V. AU - Hedegaard, M. AU - Larsson, K. PY - 2013 DA - 2013// TI - Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.04.005 DO - 10.1016/j.rmed.2013.04.005 ID - Makela2013 ER - TY - STD TI - SPIRIVA® HandiHaler® (tiotropium bromide inhalation powder) capsules for respiratory inhalation [prescribing information]. Ridgefield, CT, USA: Boehringer Ingelheim Pharmaceuticals Inc. 2014. ID - ref2 ER - TY - STD TI - Spiriva 18 microgram inhalation powder, hard capsule. SPC. Boehringer Ingelheim Ltd. http://www.medicines.org.uk/emc/medicine/10039/SPC/Spiriva+18microgram+inhalation+powder. Accessed 20 Aug 2015. UR - http://www.medicines.org.uk/emc/medicine/10039/SPC/Spiriva+18microgram+inhalation+powder ID - ref3 ER - TY - STD TI - SPIRIVA® Respimat® (tiotropium bromide) inhalation spray: for oral inhalation [prescribing information]. Ridgefield, CT, USA: Boehringer Ingelheim Pharmaceuticals, Inc. 2015. ID - ref4 ER - TY - STD TI - Spiriva (tiotropium) Respimat 2.5 micrograms, solution for inhalation. SPC. Boehringer Ingelheim Limited. https://www.medicines.org.uk/emc/medicine/20134. Accessed 20 Aug 2015. UR - https://www.medicines.org.uk/emc/medicine/20134 ID - ref5 ER - TY - STD TI - Product monograph SPIRIVA® Respimat® inhalation solution. Boehringer Ingelheim (Canada) Ltd. http://www.boehringer-ingelheim.ca/content/dam/internet/opu/ca_EN/documents/humanhealth/product_monograph/SpirivaRespimatPMEN.pdf. Accessed 20 Aug 2015. UR - http://www.boehringer-ingelheim.ca/content/dam/internet/opu/ca_EN/documents/humanhealth/product_monograph/SpirivaRespimatPMEN.pdf ID - ref6 ER - TY - JOUR AU - Keating, G. M. PY - 2014 DA - 2014// TI - Tiotropium Respimat(®) Soft Mist inhaler: a review of its use in chronic obstructive pulmonary disease JO - Drugs VL - 74 UR - https://doi.org/10.1007/s40265-014-0307-4 DO - 10.1007/s40265-014-0307-4 ID - Keating2014 ER - TY - STD TI - Health Canada. PrSTRIVERDI RESPIMAT. 17-6-2014. ID - ref8 ER - TY - JOUR AU - Brand, P. AU - Meyer, T. AU - Weuthen, T. AU - Timmer, W. AU - Berkel, E. AU - Wallenstein, G. PY - 2007 DA - 2007// TI - Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease JO - J Clin Pharmacol VL - 47 UR - https://doi.org/10.1177/0091270006295788 DO - 10.1177/0091270006295788 ID - Brand2007 ER - TY - JOUR AU - Chodosh, S. AU - Flanders, J. S. AU - Kesten, S. AU - Serby, C. W. AU - Hochrainer, D. AU - Witek, T. J. J. PY - 2001 DA - 2001// TI - Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity JO - J Aerosol Med VL - 14 UR - https://doi.org/10.1089/089426801316970268 DO - 10.1089/089426801316970268 ID - Chodosh2001 ER - TY - JOUR AU - Dalby, R. N. AU - Eicher, J. AU - Zierenberg, B. PY - 2011 DA - 2011// TI - Development of Respimat® Soft Mist Inhaler and its clinical utility in respiratory disorders JO - Med Devices (Auckl) VL - 4 ID - Dalby2011 ER - TY - JOUR AU - Anderson, P. PY - 2006 DA - 2006// TI - Use of Respimat Soft Mist inhaler in COPD patients JO - Int J Chron Obstruct Pulmon Dis VL - 1 ID - Anderson2006 ER - TY - JOUR AU - Hochrainer, D. AU - Holz, H. AU - Kreher, C. AU - Scaffidi, L. AU - Spallek, M. AU - Wachtel, H. PY - 2005 DA - 2005// TI - Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers JO - J Aerosol Med VL - 18 UR - https://doi.org/10.1089/jam.2005.18.273 DO - 10.1089/jam.2005.18.273 ID - Hochrainer2005 ER - TY - JOUR AU - Pitcairn, G. AU - Reader, S. AU - Pavia, D. AU - Newman, S. PY - 2005 DA - 2005// TI - Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler JO - J Aerosol Med VL - 18 UR - https://doi.org/10.1089/jam.2005.18.264 DO - 10.1089/jam.2005.18.264 ID - Pitcairn2005 ER - TY - JOUR AU - Zierenberg, B. PY - 1999 DA - 1999// TI - Optimizing the in vitro performance of Respimat JO - J Aerosol Med VL - 12 ID - Zierenberg1999 ER - TY - JOUR AU - Capstick, T. G. AU - Clifton, I. J. PY - 2012 DA - 2012// TI - Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma JO - Expert Rev Respir Med VL - 6 UR - https://doi.org/10.1586/ers.11.89 DO - 10.1586/ers.11.89 ID - Capstick2012 ER - TY - JOUR AU - Lippmann, M. AU - Yeates, D. B. AU - Albert, R. E. PY - 1980 DA - 1980// TI - Deposition, retention, and clearance of inhaled particles JO - Br J Ind Med VL - 37 ID - Lippmann1980 ER - TY - JOUR AU - Dalby, R. AU - Spallek, M. AU - Voshaar, T. PY - 2004 DA - 2004// TI - A review of the development of Respimat Soft Mist Inhaler JO - Int J Pharm VL - 283 UR - https://doi.org/10.1016/j.ijpharm.2004.06.018 DO - 10.1016/j.ijpharm.2004.06.018 ID - Dalby2004 ER - TY - JOUR AU - Newman, S. P. AU - Steed, K. P. AU - Reader, S. J. AU - Hooper, G. AU - Zierenberg, B. PY - 1996 DA - 1996// TI - Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizer JO - J Pharm Sci VL - 85 UR - https://doi.org/10.1021/js950522q DO - 10.1021/js950522q ID - Newman1996 ER - TY - JOUR AU - Ninane, V. AU - Vandevoorde, J. AU - Cataldo, D. AU - Derom, E. AU - Liistro, G. AU - Munghen, E. PY - 2015 DA - 2015// TI - New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences JO - Respir Med VL - 109 UR - https://doi.org/10.1016/j.rmed.2015.09.013 DO - 10.1016/j.rmed.2015.09.013 ID - Ninane2015 ER - TY - STD TI - Ciciliani A-M, Wachtel H, Langguth P. Comparing Respimat® Soft Mist™ inhaler and DPI aerosol deposition by combined in vitro measurements and CFD simulations. Presented at: Respiratory Drug Delivery 2014; 4-8 May 2014; Fajardo, Puerto Rico. ID - ref21 ER - TY - JOUR AU - Keating, G. M. PY - 2012 DA - 2012// TI - Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease JO - Drugs VL - 72 UR - https://doi.org/10.2165/11208620-000000000-00000 DO - 10.2165/11208620-000000000-00000 ID - Keating2012 ER - TY - JOUR AU - Anzueto, A. AU - Wise, R. AU - Pledger, G. AU - Calverley, P. AU - Dusser, D. AU - Cotton, D. PY - 2013 DA - 2013// TI - The Tiotropium Safety and Performance in Respimat (TIOSPIR) trial: bronchodilator efficacy in a spirometry substudy [abstract] JO - Chest VL - 144 UR - https://doi.org/10.1378/chest.1783312 DO - 10.1378/chest.1783312 ID - Anzueto2013 ER - TY - JOUR AU - Anzueto, A. AU - Wise, R. AU - Calverley, P. AU - Dusser, D. AU - Tang, W. AU - Metzdorf, N. PY - 2015 DA - 2015// TI - The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes JO - Respir Res VL - 16 UR - https://doi.org/10.1186/s12931-015-0269-4 DO - 10.1186/s12931-015-0269-4 ID - Anzueto2015 ER - TY - JOUR AU - Bouloukaki, I. AU - Giannadaki, K. AU - Merigkis, C. AU - Michelakis, S. AU - Mauroudi, E. AU - Moniaki, V. PY - 2014 DA - 2014// TI - Tiotropium Respimat versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD [abstract] JO - Eur Respir J VL - 44 ID - Bouloukaki2014 ER - TY - JOUR AU - Caillaud, D. AU - Merre, C. AU - Martinat, Y. AU - Aguilaniu, B. AU - Pavia, D. PY - 2007 DA - 2007// TI - A dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients JO - Int J Chron Obstruct Pulmon Dis VL - 2 ID - Caillaud2007 ER - TY - STD TI - Calverley P, Anzueto A, Dahl R, Meuller A, Fowler A, Metzdorf N, et al. Tiotropium Safety and Performance In Respimat® (tiospir™): safety and efficacy in patients with tiotropium Handihaler® use at baseline [abstract]. Thorax. 2014;69 Suppl 2:A192 (P262). ID - ref27 ER - TY - JOUR AU - Dahl, R. AU - Schmidt, H. AU - Könen-Bergmann, M. AU - Metzdorf, N. PY - 2014 DA - 2014// TI - Mixed treatment analysis comparing tiotropium HandiHaler® and Respimat® [abstract] JO - Eur Respir J VL - 44 ID - Dahl2014 ER - TY - JOUR AU - Dahl, R. AU - Calverley, P. AU - Anzueto, A. PY - 2015 DA - 2015// TI - Safety and efficacy of tiotropium in patients switching from HandiHaler® to Respimat® in the TIOSPIR® trial. Submitted manuscript JO - BMJ Open VL - 5 UR - https://doi.org/10.1136/bmjopen-2015-009015 DO - 10.1136/bmjopen-2015-009015 ID - Dahl2015 ER - TY - JOUR AU - Halpin, D. M. AU - Dahl, R. AU - Hallmann, C. AU - Mueller, A. AU - Tashkin, D. PY - 2015 DA - 2015// TI - Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis JO - Int J Chron Obstruct Pulmon Dis VL - 10 ID - Halpin2015 ER - TY - JOUR AU - Hohlfeld, J. M. AU - Sharma, A. AU - Noord, J. A. AU - Cornelissen, P. J. AU - Derom, E. AU - Towse, L. PY - 2014 DA - 2014// TI - Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease JO - J Clin Pharmacol VL - 54 UR - https://doi.org/10.1002/jcph.215 DO - 10.1002/jcph.215 ID - Hohlfeld2014 ER - TY - JOUR AU - Hohlfeld, J. M. AU - Furtwaengler, A. AU - Konen-Bergmann, M. AU - Wallenstein, G. AU - Walter, B. AU - Bateman, E. D. PY - 2015 DA - 2015// TI - Cardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials JO - Int J Clin Pract VL - 69 UR - https://doi.org/10.1111/ijcp.12596 DO - 10.1111/ijcp.12596 ID - Hohlfeld2015 ER - TY - JOUR AU - Ichinose, M. AU - Fujimoto, T. AU - Fukuchi, Y. PY - 2010 DA - 2010// TI - Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients JO - Respir Med VL - 104 UR - https://doi.org/10.1016/j.rmed.2009.11.011 DO - 10.1016/j.rmed.2009.11.011 ID - Ichinose2010 ER - TY - STD TI - Tashkin D, Jones P, Leonard T, Liu D, Metzdorf N, Zubeck V, Wise R. Tiotropium delivered via HandiHaler or Respimat: improvement in health-related quality of life in patients with chronic obstructive pulmonary disease [abstract]. Chest Journal. 2014;146(4_MeetingAbstracts):49A. ID - ref34 ER - TY - JOUR AU - Tashkin, D. AU - Metzdorf, N. AU - Hallmann, C. AU - Konen-Bergmann, M. AU - Kupas, K. AU - Dalby, R. PY - 2014 DA - 2014// TI - Safety of tiotropium in renally impaired patients [abstract] JO - Eur Respir J VL - 44 ID - Tashkin2014 ER - TY - JOUR AU - Tashkin, D. AU - Kowey, P. R. AU - Fowler, A. AU - Metzdorf, N. AU - Dewberry, H. AU - Mueller, A. PY - 2015 DA - 2015// TI - Cardiac safety of tiotropium in patients with cardiac events: a retrospective, combined analysis of the UPLIFT® and TIOSPIR™ trials [abstract] JO - Am J Respir Crit Care Med VL - 191 ID - Tashkin2015 ER - TY - JOUR AU - Noord, J. A. AU - Cornelissen, P. J. AU - Aumann, J. L. AU - Platz, J. AU - Mueller, A. AU - Fogarty, C. PY - 2009 DA - 2009// TI - The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients JO - Respir Med VL - 103 UR - https://doi.org/10.1016/j.rmed.2008.10.002 DO - 10.1016/j.rmed.2008.10.002 ID - Noord2009 ER - TY - JOUR AU - Verhamme, K. AU - Blijderveen, N. AU - Romio, S. AU - Stricker, B. AU - Brusselle, G. AU - Sturkenboom, M. PY - 2013 DA - 2013// TI - Chronic kidney disease as effect modifier in the association between the use of tiotropium Respimat and mortality [abstract] JO - Eur Respir J VL - 42 ID - Verhamme2013 ER - TY - JOUR AU - Verhamme, K. M. AU - Afonso, A. AU - Romio, S. AU - Stricker, B. C. AU - Brusselle, G. G. AU - Sturkenboom, M. C. PY - 2013 DA - 2013// TI - Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD JO - Eur Respir J VL - 42 UR - https://doi.org/10.1183/09031936.00005813 DO - 10.1183/09031936.00005813 ID - Verhamme2013 ER - TY - STD TI - Wise R, Calverley P, Dahl R, Dusser D, Metzdorf N, Mueller A, et al. Tiotropium safety and performance in respimat® (tiospir™): safety and efficacy in patients naïve to treatment with anticholinergics [abstract]. Thorax. 2014;69 Suppl 2:A192 (P261). ID - ref40 ER - TY - STD TI - Wise R, Fowler A, Metzdorf N, Dewberry H, Mueller A, Kowey PR. Safety of tiotropium in patients with cardiac events in the TIOSPIR® trial. Presented at: European Respiratory Society International Congress; September 26-30, 2015; 26 September 2015. ID - ref41 ER - TY - STD TI - Wise R, Kowey PR, Austen G, Lawton A, Mueller A, Metzdorf N, et al. Investigator-reported versus adjudicated cause of death in the TIOSPIR® trial. Presented at: European Respiratory Society International Congress; September 26-30, 2015; 26 September 2015. ID - ref42 ER - TY - JOUR AU - Wise, R. A. AU - Anzueto, A. AU - Calverley, P. AU - Dahl, R. AU - Dusser, D. AU - Pledger, G. PY - 2013 DA - 2013// TI - The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale JO - Respir Res VL - 14 UR - https://doi.org/10.1186/1465-9921-14-40 DO - 10.1186/1465-9921-14-40 ID - Wise2013 ER - TY - JOUR AU - Bouloukaki, I. AU - Tzanakis, N. AU - Mermigkis, C. AU - Giannadaki, K. AU - Moniaki, V. AU - Mauroudi, E. PY - 2015 DA - 2015// TI - Tiotropium Respimat Soft Mist Inhaler versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD JO - Sleep Breath VL - 20 UR - https://doi.org/10.1007/s11325-015-1259-y DO - 10.1007/s11325-015-1259-y ID - Bouloukaki2015 ER - TY - JOUR AU - Beasley, R. PY - 2013 DA - 2013// TI - Tiotropium Respimat increases the risk of mortality: pro JO - Eur Respir J VL - 42 UR - https://doi.org/10.1183/09031936.00042113 DO - 10.1183/09031936.00042113 ID - Beasley2013 ER - TY - JOUR AU - Singh, S. AU - Loke, Y. K. AU - Enright, P. L. AU - Furberg, C. D. PY - 2011 DA - 2011// TI - Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials JO - BMJ VL - 342 UR - https://doi.org/10.1136/bmj.d3215 DO - 10.1136/bmj.d3215 ID - Singh2011 ER - TY - JOUR AU - Durham, M. C. PY - 2004 DA - 2004// TI - Tiotropium (Spiriva): a once-daily inhaled anticholinergic medication for chronic obstructive pulmonary disease JO - Proc (Bayl Univ Med Cent) VL - 17 ID - Durham2004 ER - TY - JOUR AU - Wise, R. A. AU - Anzueto, A. AU - Cotton, D. AU - Dahl, R. AU - Devins, T. AU - Disse, B. PY - 2013 DA - 2013// TI - Tiotropium Respimat inhaler and the risk of death in COPD JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1303342 DO - 10.1056/NEJMoa1303342 ID - Wise2013 ER - TY - JOUR AU - Karner, C. AU - Chong, J. AU - Poole, P. PY - 2014 DA - 2014// TI - Tiotropium versus placebo for chronic obstructive pulmonary disease JO - Cochrane Database Syst Rev VL - 7 ID - Karner2014 ER - TY - JOUR AU - Kaplan, A. PY - 2010 DA - 2010// TI - Effect of tiotropium on quality of life in COPD: a systematic review JO - Prim Care Respir J VL - 19 UR - https://doi.org/10.4104/pcrj.2010.00067 DO - 10.4104/pcrj.2010.00067 ID - Kaplan2010 ER - TY - JOUR AU - Verhamme, K. M. C. AU - Afonso, A. S. AU - Romio, S. AU - Stricker, B. C. AU - Brusselle, G. G. AU - Sturkenboom, M. C. PY - 2012 DA - 2012// TI - Patient characteristics at first time use of tiotropium Handihaler vs tiotropium Respimat: is there a potential of channelling? [abstract] JO - Am J Respir Crit Care Med VL - 185 ID - Verhamme2012 ER - TY - JOUR AU - Barnes, N. C. AU - Jones, P. W. AU - Davis, K. J. PY - 2014 DA - 2014// TI - Safety of tiotropium through the Handihaler: why did meta-analyses and database studies appear to give a false alarm? JO - Thorax VL - 69 UR - https://doi.org/10.1136/thoraxjnl-2014-205155 DO - 10.1136/thoraxjnl-2014-205155 ID - Barnes2014 ER - TY - JOUR AU - Dekhuijzen, P. N. AU - Vincken, W. AU - Virchow, J. C. AU - Roche, N. AU - Agusti, A. AU - Lavorini, F. PY - 2013 DA - 2013// TI - Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.09.013 DO - 10.1016/j.rmed.2013.09.013 ID - Dekhuijzen2013 ER - TY - JOUR AU - Vincken, W. AU - Dekhuijzen, P. R. AU - Barnes, P. PY - 2010 DA - 2010// TI - ADMIT Group. The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD JO - Prim Care Respir J VL - 19 UR - https://doi.org/10.4104/pcrj.2009.00062 DO - 10.4104/pcrj.2009.00062 ID - Vincken2010 ER - TY - STD TI - Borel JC, Pepin JL, Pison C, Vesin A, Gonzalez-Bermejo J, Court-Fortune I, et al. Long-term adherence with non-invasive ventilation improves prognosis in obese COPD patients. Respirology. 2014;19:857–65. ID - ref55 ER - TY - JOUR AU - Hodder, R. AU - Price, D. PY - 2009 DA - 2009// TI - Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler JO - Int J Chron Obstruct Pulmon Dis VL - 4 UR - https://doi.org/10.2147/COPD.S3391 DO - 10.2147/COPD.S3391 ID - Hodder2009 ER - TY - JOUR AU - Melani, A. S. AU - Bonavia, M. AU - Cilenti, V. AU - Cinti, C. AU - Lodi, M. AU - Martucci, P. PY - 2011 DA - 2011// TI - Inhaler mishandling remains common in real life and is associated with reduced disease control JO - Respir Med VL - 105 UR - https://doi.org/10.1016/j.rmed.2011.01.005 DO - 10.1016/j.rmed.2011.01.005 ID - Melani2011 ER - TY - JOUR AU - Freytag, F. AU - Rau-Berger, H. AU - Glaab, T. AU - Wolf, K. PY - 2007 DA - 2007// TI - Respimat® Soft Mist™ inhaler preferred to Diskus by patients with COPD and/or asthma [abstract] JO - Am J Respir Crit Care Med VL - 175 ID - Freytag2007 ER - TY - JOUR AU - Hodder, R. AU - Reese, P. R. AU - Slaton, T. PY - 2009 DA - 2009// TI - Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler JO - Int J Chron Obstruct Pulmon Dis VL - 4 UR - https://doi.org/10.2147/COPD.S3452 DO - 10.2147/COPD.S3452 ID - Hodder2009 ER - TY - JOUR AU - Schurmann, W. AU - Schmidtmann, S. AU - Moroni, P. AU - Massey, D. AU - Qidan, M. PY - 2005 DA - 2005// TI - Respimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction JO - Treat Respir Med VL - 4 UR - https://doi.org/10.2165/00151829-200504010-00006 DO - 10.2165/00151829-200504010-00006 ID - Schurmann2005 ER - TY - STD TI - ADESPI Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice. NCT01388166. https://www.clinicaltrials.gov/ct2/show/NCT01388166. Accessed 20 Aug 2015. UR - https://www.clinicaltrials.gov/ct2/show/NCT01388166 ID - ref61 ER - TY - JOUR AU - Asakura, Y. AU - Nishimura, N. AU - Maezawa, K. AU - Terajima, T. AU - Kizu, J. AU - Chohnabayashi, N. PY - 2013 DA - 2013// TI - Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices JO - J Aerosol Med Pulm Drug Deliv VL - 26 UR - https://doi.org/10.1089/jamp.2011.0941 DO - 10.1089/jamp.2011.0941 ID - Asakura2013 ER - TY - JOUR AU - Hanada, S. AU - Wada, S. AU - Ohno, T. AU - Sawaguchi, H. AU - Muraki, M. AU - Tohda, Y. PY - 2015 DA - 2015// TI - Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch JO - Int J Chron Obstruct Pulmon Dis VL - 10 ID - Hanada2015 ER - TY - JOUR AU - Nishimura, N. AU - Asakura, Y. AU - Junta, T. AU - Suda, R. AU - Yamao, S. AU - Tomishima, Y. PY - 2014 DA - 2014// TI - Therapeutic effect of switching tiotropium HandiHaler to Respimat Soft Mist™ inhaler in the patients with COPD: the difference of adverse events and adherence to manipulations between inhaler devices [abstract] JO - Am J Respir Crit Care Med VL - 189 ID - Nishimura2014 ER - TY - JOUR AU - Suzuki, S. AU - Sagara, H. AU - Tanaka, A. AU - Yamaguchi, M. AU - Ohta, S. AU - Homma, T. PY - 2014 DA - 2014// TI - Effect of switching administration of tiotropium, HandiHaler to Respimat Soft Mist Inhaler in COPD patients: focus on physical characteristics and background of COPD patients before changing inhaler devices JO - Am J Respir Crit Care Med VL - 189 ID - Suzuki2014 ER - TY - JOUR AU - Trotta, F. AU - Cas, R. AU - Rajevic, M. AU - Rossi, M. AU - Traversa, G. PY - 2015 DA - 2015// TI - Risk factors influencing the prescription of tiotropium Respimat formulation: a population-based cohort study JO - BMJ Open VL - 5 UR - https://doi.org/10.1136/bmjopen-2014-006619 DO - 10.1136/bmjopen-2014-006619 ID - Trotta2015 ER -